Assess Safety and Efficacy of Vilaprisan in Subjects With Uterine Fibroids

NCT03194646 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

1272

Enrollment

INDUSTRY

Sponsor class

Stopped Due to a change in the development program, the study was closed prematurely.

Conditions

Uterine Fibroids

Interventions

DRUG: Vilaprisan (BAY1002670)
DRUG: Vilaprisan (BAY1002670)
DRUG: Vilaprisan (BAY1002670)
OTHER: Standard of care
DRUG: Vilaprisan (BAY1002670)
DRUG: Vilaprisan (BAY1002670)
DRUG: Vilaprisan (BAY1002670)

Sponsor

Bayer